AlphaCentric Advisors’s UroGen Pharma URGN Stock Holding History

AlphaCentric Advisors’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$2.16M	Sell
2023 Q4	$2.33M	Sell
2023 Q3	$2.31M	Buy
2023 Q2	$1.58M	Buy